SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-19-007420
Filing Date
2019-05-31
Accepted
2019-05-31 08:26:28
Documents
19
Period of Report
2019-05-29

Document Format Files

Seq Description Document Type Size
1 6-K auph-2019agm6xk.htm 6-K 17657
2 EXHIBIT 99.1 a9912019noticeofagmofshare.htm EX-99.1 14189
3 EXHIBIT 99.2 a9922019informationcircular.htm EX-99.2 1063605
4 EXHIBIT 99.3 a9932019formofproxy.htm EX-99.3 1719
5 EXHIBIT 99.4 a9942019shareholderletter.htm EX-99.4 37296
6 a2019proxy1a01.jpg GRAPHIC 109243
7 a2019proxy2.jpg GRAPHIC 93470
8 aurinialogoweb700pxa02.jpg GRAPHIC 77311
9 aurinialogoweb700pxa05.jpg GRAPHIC 77311
10 checkmarka08.jpg GRAPHIC 8132
11 checkmarka09.jpg GRAPHIC 8132
12 checkmarka10.jpg GRAPHIC 8132
13 checkmarka11.jpg GRAPHIC 8132
14 faxa01.jpg GRAPHIC 8814
15 interneta01.jpg GRAPHIC 9495
16 laurelhill.jpg GRAPHIC 13934
17 maila01.jpg GRAPHIC 8940
18 perfgraph.jpg GRAPHIC 29057
19 phone.jpg GRAPHIC 8952
  Complete submission text file 0001628280-19-007420.txt   1722977
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 19868656
SIC: 2834 Pharmaceutical Preparations